tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
RETA is currently covered by 11 analysts with an average price target of $195.86. This is a potential upside of $23.5 (13.63%) from yesterday's end of day stock price of $172.36.
Reata Pharmaceuticals's activity chart (see below) currently has 137 price targets and 101 ratings on display. The stock rating distribution of RETA is 68% BUY and 32% HOLD.
Analysts average stock forecasts to be materialized ratio is 61.63% with an average time for these price targets to be met of 171.5 days.
Highest price target for RETA is $169, Lowest price target is $31, average price target is $195.86.
Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 15-Aug-2023. First documented stock forecast 20-Jun-2016.
Currently out of the existing stock ratings of RETA, 17 are a BUY (68%), 8 are a HOLD (32%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$172
$-0.36 (-0.21%)
$145
1 years 3 months 8 days ago
(15-Aug-2023)
9/15 (60%)
$2.87 (1.70%)
158
Hold
$172
$-0.36 (-0.21%)
$110
1 years 3 months 22 days ago
(01-Aug-2023)
7/7 (100%)
$5.9 (3.55%)
206
Buy
$172.5
$0.14 (0.08%)
$140
1 years 3 months 22 days ago
(01-Aug-2023)
1/2 (50%)
$6.4 (3.85%)
22
Hold
$127
$-45.36 (-26.32%)
$120
1 years 3 months 23 days ago
(31-Jul-2023)
14/22 (63.64%)
$-38.58 (-23.30%)
237
Hold
$173
$0.64 (0.37%)
$40
1 years 3 months 23 days ago
(31-Jul-2023)
8/12 (66.67%)
$7.42 (4.48%)
184
What is RETA (Reata Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on RETA (Reata Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on RETA (Reata Pharmaceuticals)?
Which analyst is the currently most bullish on RETA (Reata Pharmaceuticals)?
Which analyst is the currently most reserved on RETA (Reata Pharmaceuticals)?
